Press release
Absorbable Hemostatic Agents Market Size
The global market for Absorbable Hemostatic Agents was valued at US$ 2986 million in the year 2024 and is projected to reach a revised size of US$ 4763 million by 2031, growing at a CAGR of 7.0% during the forecast period.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-37D12664/Global_Absorbable_Hemostatic_Agents_Industry_Research_Report_Growth_Trends_and_Competitive_Analysis_2022_2028
The Absorbable Hemostatic Agents Market is experiencing steady market growth, driven by the increasing number of surgical procedures and the growing need for effective bleeding control solutions. These agents are widely used to achieve rapid hemostasis during surgeries and trauma care, making them essential in modern healthcare settings. One of the key market trends influencing the market size is the rising prevalence of chronic diseases and injuries that require surgical intervention, including cardiovascular conditions, orthopedic disorders, and cancer-related surgeries. Additionally, the increasing adoption of minimally invasive surgical techniques is boosting demand for advanced hemostatic products that are easy to apply and highly effective. Technological advancements in biomaterials, including the development of bioresorbable and biocompatible agents, are further enhancing product performance and safety. Growing awareness among healthcare professionals regarding efficient blood loss management is also contributing to market growth. These factors collectively support a strong market forecast, with continued expansion expected in the coming years.
From a type segmentation perspective, gelatin sponge-based hemostatic agents hold the largest market share due to their high absorbency, effectiveness, and widespread use in surgical procedures. These products are commonly used across various medical specialties, contributing significantly to the overall market size. Gauze-based hemostatic agents also represent a major segment, particularly in general surgery and emergency care settings where ease of use is critical. Powder-based hemostatic agents are among the fastest-growing segments, driven by their ability to quickly cover irregular wound surfaces and provide rapid clot formation. Their increasing use in minimally invasive procedures and trauma care is supporting strong market growth. Other types, including advanced composite and specialty hemostatic materials, further expand the market landscape. The demand for versatile and efficient bleeding control solutions continues to shape key market trends.
In terms of application segmentation, hospitals account for the largest market share, as they perform a high volume of surgical procedures and require reliable hemostatic solutions across multiple departments. The increasing number of complex surgeries and the need for effective intraoperative bleeding management are significantly contributing to the overall market size in this segment. Clinics represent a growing application area, particularly with the rise of outpatient and ambulatory surgical procedures. Among all applications, clinics are the fastest-growing segment, driven by the expansion of minimally invasive treatments and the shift toward cost-effective healthcare delivery models. Other applications, including emergency and specialty care centers, also contribute to market growth. The expanding application scope highlights evolving market trends and supports a positive market forecast.
The competitive landscape of the Absorbable Hemostatic Agents Market is characterized by the presence of leading global medical device companies and emerging regional players focusing on innovation, product development, and strategic expansion to strengthen their market share. Johnson & Johnson, Baxter, and B. Braun are among the major players with strong product portfolios and global distribution networks. BD is also a key participant, offering a wide range of surgical and wound care products. GELITA Medical and Curasan AG are known for their expertise in biomaterials and regenerative solutions. Meril Life Sciences is an emerging player expanding its presence in global markets. Cura Medical and Biotemed further contribute with specialized hemostatic solutions. These companies are investing in research and development to improve product efficacy, enhance biocompatibility, and expand clinical applications. Strategic partnerships, regulatory approvals, and geographic expansion are key strategies enabling companies to strengthen their market share and drive market growth.
Regionally, North America holds a dominant market share in the Absorbable Hemostatic Agents Market, driven by advanced healthcare infrastructure, high surgical volumes, and strong adoption of innovative medical technologies. Europe also represents a significant market, supported by increasing healthcare investments and a well-established medical device industry. Asia-Pacific is the fastest-growing region, fueled by improving healthcare infrastructure, rising medical tourism, and increasing awareness of advanced surgical products in countries such as China, Japan, South Korea, and India. Southeast Asia is emerging as a high-growth region, supported by expanding healthcare access and rising demand for quality medical treatments. Latin America is gradually expanding its presence, driven by growing healthcare investments in countries such as Brazil and Mexico. The Middle East and Africa are also showing potential, supported by improving healthcare facilities and increasing adoption of advanced medical technologies. Looking ahead, the market forecast remains highly positive, with continued market growth expected as surgical volumes increase, healthcare systems modernize, and demand for effective and safe bleeding control solutions continues to rise.
Segment by Type
• Gauze
• Powder
• Gelatin Sponge
• Other
Segment by Application
• Hospital
• Clinics
• Others
By Company
Johnson & Johnson, BD, Baxter, B.Braun, Cura Medical, GELITA MEDICAL, Curasan AG, Meril Life Sciences, Zhonghui Shengxi, Beijing Datsing Bio-tech, Guizhou Jin Jiu Biotech, Beijing Taikesiman, Foryou Medical, Saikesaisi Holdings Group, Biotemed
View full report
https://reports.valuates.com/market-reports/QYRE-Auto-37D12664/global-absorbable-hemostatic-agents
Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,
Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.
This release was published on openPR.
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
Delete press release Edit press release News-ID: 4502745 • Views: 5
